Cross Country Healthcare 관리

관리 기준 확인 2/4

Cross Country Healthcare CEO는 John Martins, Apr2022 에 임명되었습니다 의 임기는 3.08 년입니다. 총 연간 보상은 $ 3.54M, 24.7% 로 구성됩니다. 24.7% 급여 및 75.3% 보너스(회사 주식 및 옵션 포함). 는 € 1.89M 가치에 해당하는 회사 주식의 0.46% 직접 소유합니다. 1.89M. 경영진과 이사회의 평균 재임 기간은 각각 4.1 년과 5 년입니다.

주요 정보

John Martins

최고 경영자

US$3.5m

총 보상

CEO 급여 비율	24.71%
CEO 임기	3.1yrs
CEO 소유권	0.5%
경영진 평균 재임 기간	4.1yrs
이사회 평균 재임 기간	5yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

John Martins 의 보수는 Cross Country Healthcare 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2025	n/a	n/a	-US$18m
Dec 31 2024	US$4m	US$875k	-US$15m
Sep 30 2024	n/a	n/a	-US$2m
Jun 30 2024	n/a	n/a	US$8m
Mar 31 2024	n/a	n/a	US$46m
Dec 31 2023	US$4m	US$869k	US$73m
Sep 30 2023	n/a	n/a	US$102m
Jun 30 2023	n/a	n/a	US$124m
Mar 31 2023	n/a	n/a	US$156m
Dec 31 2022	US$3m	US$647k	US$186m
Sep 30 2022	n/a	n/a	US$227m
Jun 30 2022	n/a	n/a	US$216m
Mar 31 2022	n/a	n/a	US$175m
Dec 31 2021	US$1m	US$397k	US$132m

보상 대 시장: John 의 총 보상 ($USD 3.54M )은 German 시장( $USD 917.60K ).

보상과 수익: 회사가 수익성이 없는 동안 John 의 보상이 증가했습니다.

CEO

John Martins (56 yo)

3.1yrs

테뉴어

US$3,541,144

보상

Mr. John A. Martins has been the President, Chief Executive Officer and a Director of Cross-Country Healthcare, Inc. since April 02022. He had been the Group President of Delivery at Cross Country Healthca...

리더십 팀

이름	위치	테뉴어	보상	소유권
Kevin Clark	Co-Founder & Non-Executive Chairman of the Board	6.3yrs	US$310.00k	2% € 8.2m
John Martins	President	3.1yrs	US$3.54m	0.46% € 1.9m
William Burns	Executive VP & CFO	6.3yrs	US$1.51m	0.74% € 3.0m
Phillip Noe	Chief Information Officer	4.1yrs	US$679.12k	0.031% € 129.1k
Susan Ball	Chief Administrative Officer	21yrs	US$1.19m	0.57% € 2.3m
Marc Krug	Group President of Delivery	no data	US$966.17k	0.11% € 435.9k
James Redd	Senior VP & Chief Accounting Officer	2.5yrs	데이터 없음	0.057% € 235.1k
Joshua Vogel	Vice President of Investor Relations	3.2yrs	데이터 없음	데이터 없음
Karen Varga-Sinka	Director of Corporate Communications	no data	데이터 없음	데이터 없음
Gerald Purgay	Chief Marketing Officer	4.2yrs	데이터 없음	데이터 없음
Mark Fortunato	Vice President of Corporate Development	no data	데이터 없음	데이터 없음
Colin McDonald	Chief Human Resources Officer	no data	데이터 없음	0.076% € 311.7k

4.1yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 관리: XXY 의 관리팀은 경험 ( 4.1 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Kevin Clark	Co-Founder & Non-Executive Chairman of the Board	6.3yrs	US$310.00k	2% € 8.2m
John Martins	President	3.1yrs	US$3.54m	0.46% € 1.9m
W. Cash	Lead Independent Director	23.6yrs	US$250.00k	0.61% € 2.5m
Gale Fitzgerald	Independent Director	18yrs	US$237.25k	0.54% € 2.2m
Janice Nevin	Independent Director	5yrs	US$225.00k	0.10% € 420.3k
Dwayne Allen	Independent Director	2.3yrs	US$225.00k	0.045% € 185.0k
Venkat Bhamidipati	Independent Director	2.5yrs	US$250.00k	0.045% € 184.5k

5.0yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: XXY 의 이사회는 경험(평균 재직 기간 5 년)으로 간주됩니다.

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2025/05/19 15:50
장 마감 주가	2025/05/16 00:00
수익	2025/03/31
연간 수익	2024/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처는 미국 증권의 예를 사용했습니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 Github에서 확인할 수 있습니다.

애널리스트 출처

Cross Country Healthcare, Inc. 23 애널리스트 중 5 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Kevin Steinke	Barrington Research Associates, Inc.
William Sutherland	Benchmark Company
Jeffrey Silber	BMO Capital Markets Equity Research

Cross Country Healthcare 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Insider recently sold €216k worth of stock

Chief Information Officer recently sold €126k worth of stock

Cross Country Healthcare, Inc., Annual General Meeting, May 14, 2024

Insider recently sold €97k worth of stock

Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024

Senior VP & Chief Accounting Officer recently sold €135k worth of stock

Recent updates

Aya Healthcare, Inc. entered into a definitive agreement to acquire Cross Country Healthcare, Inc. (NasdaqGS:CCRN) for approximately $620 million.

Third quarter 2024 earnings released: EPS: US$0.077 (vs US$0.37 in 3Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Cross Country Healthcare, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Insider recently sold €216k worth of stock

Second quarter 2024 earnings released: US$0.47 loss per share (vs US$0.60 profit in 2Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2024

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 16%

Cross Country Healthcare, Inc. to Report Q2, 2024 Results on Jul 31, 2024

Chief Information Officer recently sold €126k worth of stock

First quarter 2024 earnings released: EPS: US$0.079 (vs US$0.82 in 1Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Cross Country Healthcare, Inc. Releases Latest Research Findings in the Fourth Annual Installment of the Future of Nursing Survey

Cross Country Healthcare, Inc. to Report Q1, 2024 Results on May 01, 2024

Cross Country Healthcare, Inc., Annual General Meeting, May 14, 2024

Insider recently sold €97k worth of stock

New minor risk - Share price stability

Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024

Full year 2023 earnings released: EPS: US$2.07 (vs US$5.09 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Now 23% undervalued after recent price drop

Cross Country Healthcare, Inc. to Report Q4, 2023 Results on Feb 21, 2024

Senior VP & Chief Accounting Officer recently sold €135k worth of stock

Investor sentiment deteriorates as stock falls 22%

Insider recently sold €122k worth of stock

Third quarter 2023 earnings released: EPS: US$0.37 (vs US$0.94 in 3Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023

Cross Country Healthcare, Inc. to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: US$0.60 (vs US$1.41 in 2Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2023 and Updates Earnings Guidance for the Year 2023

Cross Country Healthcare, Inc. to Report Q2, 2023 Results on Aug 02, 2023

Cross Country Launches New Xperience App, Creating Comprehensive and Intuitive Job Searching Experience for Healthcare Professionals

First quarter 2023 earnings released: EPS: US$0.82 (vs US$1.67 in 1Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2023

Full year 2022 earnings released: EPS: US$5.09 (vs US$3.60 in FY 2021)

Investor sentiment improves as stock rises 15%

Cross Country Healthcare, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Cross Country Healthcare, Inc. Appoints Eric Christianson as Its SVP, Intellify Solutions

Cross Country Healthcare, Inc. Appoints Dwayne L. Allen as Board of Directors

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Hireup Leadership Inc.

Investor sentiment deteriorated over the past week

Cross Country Healthcare, Inc. Announces Venkat Bhamidipati as Member of Board of Directors

Cross Country Healthcare, Inc. Promotes James V. Redd III to Senior Vice President and Chief Accounting Officer

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.94 (vs US$0.63 in 3Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Cross Country Healthcare, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Substantially all of the assets of Mint Medical Physician Staffing, LP & Lotus Medical Staffing LLC from Mint Medical Physician Staffing, LP and Lotus Medical Staffing.

Cross Country Healthcare, Inc. Terminates Employment of Buffy S. White as Group President, Workforce solutions

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. Revising Financial Guidance for the Third Quarter of 2022

Cross Country Healthcare Launches the New Crosscountry.Com

President recently bought €101k worth of stock

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) announces an Equity Buyback for $100 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$1.41 (vs US$0.32 in 2Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2022

Cross Country Healthcare, Inc. Appoints Craig Hoven as Senior Vice President and Managing Consultant of Cejka Search

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Cross Country Healthcare, Inc.(NasdaqGS:CCRN) dropped from Russell 2000 Value-Defensive Index

First quarter 2022 earnings released: EPS: US$1.67 (vs US$0.54 in 1Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Cross Country Healthcare, Inc. to Report Q1, 2022 Results on May 04, 2022

Cross Country Healthcare Appoints Daniel J. White to New Chief Commercial Officer

Cross Country Healthcare, Inc., Annual General Meeting, May 17, 2022

Chief Administrative Officer recently sold €333k worth of stock